دورية أكاديمية
أعرض في EDS

Initial Single-Site Surgical Experience with SMILE: A Comparison of Results to FDA SMILE, and the Earliest and Latest Generation of LASIK.

التفاصيل البيبلوغرافية
العنوان: Initial Single-Site Surgical Experience with SMILE: A Comparison of Results to FDA SMILE, and the Earliest and Latest Generation of LASIK.
المؤلفون: Moshirfar M; Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT, USA. cornea2020@me.com.; Utah Lions Eye Bank, Murray, UT, USA. cornea2020@me.com.; HDR Research Center, Hoopes Vision, Draper, UT, USA. cornea2020@me.com., Murri MS; Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT, USA., Shah TJ; University of Arizona College of Medicine, Phoenix, Phoenix, AZ, USA., Linn SH; HDR Research Center, Hoopes Vision, Draper, UT, USA., Ronquillo Y; HDR Research Center, Hoopes Vision, Draper, UT, USA., Birdsong OC; HDR Research Center, Hoopes Vision, Draper, UT, USA., Hoopes PC Jr; HDR Research Center, Hoopes Vision, Draper, UT, USA.
المصدر: Ophthalmology and therapy [Ophthalmol Ther] 2018 Dec; Vol. 7 (2), pp. 347-360. Date of Electronic Publication: 2018 Jun 29.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Healthcare Country of Publication: England NLM ID: 101634502 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8245 (Print) NLM ISO Abbreviation: Ophthalmol Ther Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [London] : Springer Healthcare
مستخلص: Introduction: The primary objective was to show our initial surgical single-site experience with small incision lenticule extraction (SMILE) after the official enrollment in March 2017 following Food and Drug Administration (FDA) approval for simple myopia in late 2016 in the United States and, subsequently, compare our results to the earliest and most advanced generation of excimer platforms for laser-assisted in situ keratomileusis (LASIK) surgery.
Methods: This was a retrospective single-site study of 68 eyes from 35 patients who had SMILE surgery. The patients' preoperative and postoperative uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest sphere, manifest cylinder, intraoperative complications, and preoperative and postoperative visual symptoms were collected. We compared our findings to the results from the FDA SMILE study, and to the three earliest (1999-2000) and three of the most updated (2013-2016) platforms for LASIK.
Results: The cumulative UDVA was 20/20 and 20/40 or better in 74% and 100% of patients, respectively. The intended target refraction was within ± 0.5 and ± 1.00 D in 80% and 93% of cases, respectively. The prevalence of dry eyes decreased by nearly half from 1-week to the 6-month postoperative interval. Patients noted improvement in glare (17%), halos (17%), fluctuation (25%), and depth perception (8%) at the 6-month interval compared to preoperative levels.
Conclusions: This study's findings are consistent with current SMILE reports. Notably, the results are superior to the earliest generation of LASIK, however inferior to the latest excimer platforms. SMILE does meet the efficacy and safety criteria met by FDA; however, there is a definite need for further improvement to reach the superior refractive outcomes produced by the latest generation of LASIK platforms.
References: Eur J Ophthalmol. 2017 Mar 10;27(2):153-159. (PMID: 27445075)
Eye Vis (Lond). 2017 Nov 15;4:26. (PMID: 29167808)
Br J Ophthalmol. 2011 Mar;95(3):335-9. (PMID: 20601657)
Klin Monbl Augenheilkd. 2017 Jan;234(1):70-76. (PMID: 27643602)
PLoS One. 2017 Aug 3;12(8):e0182251. (PMID: 28771544)
Eye Vis (Lond). 2014 Oct 16;1:3. (PMID: 26605350)
J Cataract Refract Surg. 2013 Jun;39(6):952-4. (PMID: 23688883)
Br J Ophthalmol. 2016 Apr;100(4):553-9. (PMID: 26206791)
J Cataract Refract Surg. 2011 Jan;37(1):127-37. (PMID: 21183108)
Cornea. 2008 Sep;27 Suppl 1:S70-6. (PMID: 18813078)
Br J Ophthalmol. 2016 Sep;100(9):1192-5. (PMID: 26746577)
Am J Ophthalmol. 2017 Jul;179:159-170. (PMID: 28499707)
BMC Ophthalmol. 2014 Oct 03;14:117. (PMID: 25280533)
J Refract Surg. 2014 Dec;30(12):812-8. (PMID: 25437479)
Optom Vis Sci. 2015 Jan;92(1):123-31. (PMID: 25397926)
Am J Ophthalmol. 2014 Jan;157(1):128-134.e2. (PMID: 24112634)
Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):399-405. (PMID: 26589231)
J Refract Surg. 2017 Jun 1;33(6):362-368. (PMID: 28586495)
J Cataract Refract Surg. 2016 Aug;42(8):1224-34. (PMID: 27531300)
Medicine (Baltimore). 2017 Jul;96(30):e7409. (PMID: 28746183)
BMC Ophthalmol. 2015 Jun 10;15:59. (PMID: 26059895)
PLoS One. 2016 Jul 01;11(7):e0158176. (PMID: 27367803)
J Refract Surg. 2016 Aug 1;32(9):604-10. (PMID: 27598730)
Ophthalmology. 2015 Apr;122(4):669-76. (PMID: 25458707)
Cornea. 2017 Nov;36(11):1377-1382. (PMID: 28799958)
J Cataract Refract Surg. 2004 Feb;30(2):287-90. (PMID: 15030802)
J Cataract Refract Surg. 2015 Mar;41(3):652-65. (PMID: 25804585)
Ophthalmology. 2003 Dec;110(12):2302-9. (PMID: 14644711)
J Refract Surg. 1996 Sep-Oct;12(6):721-8. (PMID: 8895129)
Indian J Ophthalmol. 2018 Jan;66(1):10-19. (PMID: 29283117)
Arch Ophthalmol. 2000 May;118(5):615-21. (PMID: 10815152)
J Refract Surg. 2018 Jan 1;34(1):11-16. (PMID: 29315436)
Arch Ophthalmol. 1998 Nov;116(11):1496-504. (PMID: 9823352)
BMJ Open. 2016 Sep 21;6(9):e010993. (PMID: 27655258)
J Refract Surg. 2017 May 1;33(5):298-304. (PMID: 28486720)
J Refract Surg. 2011 Jan;27(1):7-9. (PMID: 21229953)
BMC Ophthalmol. 2017 Jul 6;17(1):118. (PMID: 28683793)
Ophthalmology. 2017 Jun;124(6):813-821. (PMID: 28318639)
J Refract Surg. 2014 Sep;30(9):590-6. (PMID: 25250415)
J Refract Surg. 1998 Jul-Aug;14(4):467-9. (PMID: 9699173)
J Fr Ophtalmol. 2017 Jun;40(6):e201-e209. (PMID: 28601344)
Eye Vis (Lond). 2015 Dec 26;2:21. (PMID: 26709375)
Cornea. 2016 Apr;35(4):523-30. (PMID: 26890662)
معلومات مُعتمدة: Unrestricted Research to Prevent Blindness
فهرسة مساهمة: Keywords: Alcon Contoura; SMILE astigmatism; SMILE dry eyes; SMILE improvements; SMILE symptoms; SMILE vs. LASIK; VISX iDesign; Visumax femtosecond laser; Wavefront
تواريخ الأحداث: Date Created: 20180701 Latest Revision: 20220716
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC6258580
DOI: 10.1007/s40123-018-0137-7
PMID: 29959753
قاعدة البيانات: MEDLINE
كن أول من يترك تعليقا!
يجب تسجيل دخولك أولا